JOHANNESBURG, Dec 12 (Reuters) – Aspen Pharmacare (APNJ.J) has wrapped up pacts to secure funding of $30 million from the Gates Foundation and the Coalition for Epidemic Preparedness Innovations to help make affordable vaccines for Africa, the company said on Monday.
In August, Aspen announced a deal with the Serum Institute of India to make and sell four Aspen-branded vaccines for Africa, as it looks to use its near-idle COVID-19 vaccine…
